Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
drug research & discoverydrug research & discoveryBioTech/DrugsCommercial Physical ResearchBiotechnology